CREATINE KINASE (CK) - ANVISA Registration 80048490061
Access comprehensive regulatory information for CREATINE KINASE (CK) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80048490061 and manufactured by MONOBIND INC. The registration is held by USA DIAGNOSTICA LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including GOLD ANALISA DIAGNOSTICA LTDA, KATAL BIOTECNOLOGICA INDÚSTRIA E COMÉRCIO LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
80048490061
25351316198201037
02330159000108
Company Information
Dates and Status
Feb 06, 2012
VIGENTE
09/18/2025 19:00:01
CREATINOQUINASE (CK)
Família CK NAC
GOLD ANALISA DIAGNOSTICA LTDA
80022230299
Aug 18, 2025
CREATINOQUINASE (CK)
FAMÍLIA CK TOTAL
KATAL BIOTECNOLOGICA INDÚSTRIA E COMÉRCIO LTDA
10377390318
Jun 02, 2025
CREATINOQUINASE (CK)
CK NAC Automação - Linha DT
DAILYTECH LATINO AMERICA LTDA
80657030079
Apr 07, 2025
CREATINOQUINASE (CK)
CK-NAC
IN VITRO DIAGNOSTICA LTDA
10303460560
Mar 17, 2025
CREATINOQUINASE (CK)
CK (W) Simplex
TASCOM CO., LTD
80074330020
Feb 17, 2025

